Wednesday, May 27, 2026
BodyM Publishing Standard

Editorial policy.

The rules we use to keep GLP-1 tracker content useful, source-grounded, and safely separated from medical care.

01

What BodyM publishes

BodyM publishes GLP-1 tracking education for people organizing shots, weight trend, body and face progress photos, side effects, food tolerance, hydration, protein, and clinician questions.

02

Medical boundary

BodyM does not diagnose, prescribe, adjust medication, replace a clinician, or provide emergency care. Content is written to help users track context and prepare better questions for licensed professionals.

03

Source standard

Medication, symptom, and safety references favor official labels, FDA resources, MedlinePlus, NIDDK, Mayo Clinic, and other high-trust sources. Product and tracker pages should cite the sources that shape their claims.

04

AI-assisted content

Some guide pages use structured templates or AI-assisted drafting. Before publication, pages should be checked for factual grounding, duplicated language, unsafe medical claims, and whether the visible content matches structured data.

05

Community safety

Community prompts are designed for peer support and tracking context. BodyM should avoid encouraging medication trading, dose instructions, diagnosis, emergency self-management, or supplement claims that imply disease treatment.

06

Update rhythm

Core guide pages should be reviewed when major prescribing labels, FDA safety communication, platform policy, or GLP-1 user behavior changes. Search pages should also be refreshed when data shows new high-intent topics.